Note 22 - Fair Value Disclosures (Tables)

12 Months Ended

Dec. 31, 2018

Notes Tables

Fair Value, by Balance Sheet Grouping [Table Text Block]

	Fair Value Measured at Reporting Date Using
	Carrying Amount		Level 1		Level 2		Level 3		Fair Value
At December 31, 2018:
Cash and cash equivalents	$	3,193	$	-	$	3,193	$	-	$	3,193
Other receivables	$	418,905	$	-	$	-	$	418,905	$	418,905
Note receivable - related party	$	44,859	$	-	$	-	$	44,859	$	44,859
Advances to CEN Biotech
Ukraine, LLC - related party	$	875,328	$	-	$	-	$	875,328	$	875,328
Loans payable	$	10,107,205	$	-	$	-	$	10,107,205	$	10,107,205
Loans payable – related parties	$	1,360,806	$	-	$	-	$	-	$	-
Patent acquisition liability	$	1,010,000	$	-	$	-	$	1,010,000	$	1,010,000
Convertible notes payable	$	5,143,647	$	-	$	-	$	5,534,810	$	5,534,810
Convertible notes payable – related parties	$	2,538,681	$	-	$	-	$	-	$	-

	Carrying Amount		Level 1		Level 2		Level 3		Fair Value
At December 31, 2017:
Cash and cash equivalents	$	84,978	$	-	$	84,978	$	-	$	84,978
Other receivables	$	222,562	$	-	$	-	$	222,562	$	222,562
Note receivable - related party	$	44,859	$	-	$	-	$	44,859	$	44,859
Advances to CEN Biotech
Ukraine, LLC - related party	$	775,328	$	-	$	-	$	775,328	$	775,328
Loans payable	$	9,981,883	$	-	$	-	$	9,981,883	$	9,981,883
Loans payable – related parties	$	1,138,923	$	-	$	-	$	-	$	-
Convertible notes payable	$	3,670,172	$	-	$	-	$	3,831,760	$	3,831,760
Convertible notes payable – related parties	$	2,710,313	$	-	$	-	$	-	$	-